Please assess the completion status of the following clinical trial:

Trial Title: Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Informed consent by parent/guardian (written or oral)~* Permanent residentship in the study area~* Age of 3 months +/-4 weeks~Exclusion Criteria:~* Hypersensitivity to sulfonamides or pyrimethamine (skin rashes, evidence of hemolysis including dark urine and/or purpura, presumptive signs of bone marrow depression such as sore throat and/or mouth ulcers)~* Other severe adverse events related to pyrimethamine-sulfadoxine application~* Signs of severe hepatic or renal dysfunction not due to malaria~* Other reasons after decision of the study physician

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 4 Months
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).